Kathy Miller , a breast cancer expert at Indiana University who has worked on trials of Sutent and Genentech's Avastin, says that her patients are verygood at understanding that if a drug is keeping their tumors from growing, that is often good enough.
"It's averygood idea to train people into understanding their own language, " he said, explaining that the awards were designed to shine light on the misuse of grammar in modern society.